APA (7th ed.) Citation

Janssen, M., Schmidt, C., Bruch, P., Blank, M. F., Rohde, C., Waclawiczek, A., . . . Dietrich, S. (2022). Venetoclax synergizes with gilteritinib in FLT3 wild-type high-risk acute myeloid leukemia by suppressing MCL-1. Blood, 140(24), . https://doi.org/10.1182/blood.2021014241

Chicago Style (17th ed.) Citation

Janssen, Maike, et al. "Venetoclax Synergizes with Gilteritinib in FLT3 Wild-type High-risk Acute Myeloid Leukemia by Suppressing MCL-1." Blood 140, no. 24 (2022). https://doi.org/10.1182/blood.2021014241.

MLA (9th ed.) Citation

Janssen, Maike, et al. "Venetoclax Synergizes with Gilteritinib in FLT3 Wild-type High-risk Acute Myeloid Leukemia by Suppressing MCL-1." Blood, vol. 140, no. 24, 2022, https://doi.org/10.1182/blood.2021014241.